A college student in Reading, Berkshire, has died from meningitis, with two additional cases currently under treatment in the area. The outbreak highlights the importance of recognizing meningitis symptoms and understanding prevention options.
Meningitis causes inflammation of the membranes surrounding the brain and spinal cord. Symptoms develop rapidly and include high fever, severe headache, stiff neck, sensitivity to light, nausea, vomiting, and confusion or drowsiness. A rash may appear in some cases, particularly with meningococcal meningitis. Infants may show different signs: unusual crying, difficulty feeding, or excessive sleepiness. Anyone experiencing these symptoms requires immediate emergency care.
The disease spreads through respiratory droplets and close contact with infected people. Meningitis can be bacterial, viral, or fungal. Bacterial meningitis proves most serious and progresses fastest, sometimes causing death or permanent disability within hours of symptom onset.
Vaccines offer protection against several meningitis types. In the UK, the meningococcal B vaccine (Bexsero) protects against serogroup B, responsible for most UK cases in recent years. The meningococcal ACWY vaccine (Nimenrix) covers serogroups A, C, W, and Y. Routine childhood vaccination includes protection against meningococcal C. College students, particularly those living in halls of residence, face increased risk of meningococcal meningitis and typically receive the ACWY vaccine if not previously given.
People who have had close contact with a confirmed meningitis patient should receive antibiotics or vaccines depending on the type of meningitis involved. Healthcare providers can assess exposure risk and recommend appropriate preventive measures.
Early recognition and rapid treatment with antibiotics can save lives. Most cases require hospitalization and intravenous